Gene: ADO
Official Full Name: 2-aminoethanethiol dioxygenaseprovided by HGNC
Gene Summary: Human thiol dioxygenases include cysteine dioxygenase (CDO; MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO; EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007 [PubMed 17581819]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24547 | ADO Knockout cell line (HeLa) | Human | ADO | 1:3~1:6 | Negative | Online Inquiry |
KO24548 | ADO Knockout cell line (HCT 116) | Human | ADO | 1:2~1:4 | Negative | Online Inquiry |
KO24549 | ADO Knockout cell line (HEK293) | Human | ADO | 1:3~1:6 | Negative | Online Inquiry |
KO24550 | ADO Knockout cell line (A549) | Human | ADO | 1:3~1:4 | Negative | Online Inquiry |
ADO Gene Knockout Cell Lines are a cutting-edge tool in molecular biology designed to facilitate targeted gene function studies by creating stable cell models lacking specific genes of interest. Through the application of CRISPR-Cas9 or other gene editing technologies, these cell lines demonstrate precise gene knockout capabilities that enable researchers to investigate gene function, elucidate biochemical pathways, and assess cellular responses in a controlled environment.
The core mechanism involves the disruption of the targeted gene sequence, preventing the production of its associated protein. This allows for the in-depth study of gene roles and interactions, impacting areas such as cancer research, developmental biology, and drug discovery. ADO Gene Knockout Cell Lines are invaluable for applications that require gene functional analysis and provide a robust platform for therapeutic studies, genetic screening, and modeling diseases.
What sets ADO Gene Knockout Cell Lines apart from alternatives is their meticulous validation process, ensuring high specificity and efficiency in gene disruption. These cell lines are also extensively characterized for consistent performance across experimental conditions, reducing variability and increasing reliability in research outcomes.
For researchers and clinicians, the ability to generate and utilize these knockout models accelerates discovery and innovation in therapy development. The implications of improved understanding of gene function can enhance precision medicine strategies, leading to more effective treatments.
With a commitment to scientific integrity, our company specializes in providing premium biological products backed by rigorous research and quality control. Our extensive portfolio of customized solutions, including ADO Gene Knockout Cell Lines, empowers researchers to achieve groundbreaking findings while streamlining their workflows.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.